High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinomaSven H. Loosen, Tom Luedde, Niklas Püthe et al.|Carcinogenesis|2019Cited by 28